Cytomegalovirus Immunoglobulin After Thoracic Transplantation: An Overview

Grossi, Paolo; Mohacsi, Paul; Szabolcs, Zoltán; Potena, Luciano (2016). Cytomegalovirus Immunoglobulin After Thoracic Transplantation: An Overview. Transplantation, 100(3S), S1-S4. Lippincott Williams & Wilkins 10.1097/TP.0000000000001094

[img]
Preview
Text
OA-108, Grossi_Cytomegalovirus Immunoblobulin....pdf - Published Version
Available under License Creative Commons: Attribution-Noncommercial-No Derivative Works (CC-BY-NC-ND).

Download (282kB) | Preview

Cytomegalovirus (CMV) is a highly complex pathogen which, despite modern prophylactic regimens, continues to affect a high proportion of thoracic organ transplant recipients. The symptomatic manifestations of CMV infection are compounded by adverse indirect effects induced by the multiple immunomodulatory actions of CMV. These include a higher risk of acute rejection, cardiac allograft vasculopathy after heart transplantation, and potentially bronchiolitis obliterans syndrome in lung transplant recipients, with a greater propensity for opportunistic secondary infections. Prophylaxis for CMV using antiviral agents (typically oral valganciclovir or intravenous ganciclovir) is now almost universal, at least in high-risk transplants (D+/R-). Even with extended prophylactic regimens, however, challenges remain. The CMV events can still occur despite antiviral prophylaxis, including late-onset infection or recurrent disease, and patients with ganciclovir-resistant CMV infection or who are intolerant to antiviral therapy require alternative strategies. The CMV immunoglobulin (CMVIG) and antiviral agents have complementary modes of action. High-titer CMVIG preparations provide passive CMV-specific immunity but also exert complex immunomodulatory properties which augment the antiviral effect of antiviral agents and offer the potential to suppress the indirect effects of CMV infection. This supplement discusses the available data concerning the immunological and clinical effects of CMVIG after heart or lung transplantation

Item Type:

Journal Article (Original Article)

Division/Institute:

04 Faculty of Medicine > Department of Cardiovascular Disorders (DHGE) > Clinic of Cardiology

UniBE Contributor:

Mohacsi, Paul

Subjects:

600 Technology > 610 Medicine & health

ISSN:

0041-1337

Publisher:

Lippincott Williams & Wilkins

Language:

English

Submitter:

Alessandra Witsch

Date Deposited:

26 Jul 2016 11:50

Last Modified:

05 Dec 2022 14:57

Publisher DOI:

10.1097/TP.0000000000001094

PubMed ID:

26900989

BORIS DOI:

10.7892/boris.84093

URI:

https://boris.unibe.ch/id/eprint/84093

Actions (login required)

Edit item Edit item
Provide Feedback